Real-Time Survey of Vaccine Safety of the mRNA-1273 SARS-CoV-2 Vaccine in Workplace Vaccination at Keio University

The mRNA-1273 Moderna COVID-19 vaccine was introduced to combat the COVID-19 global pandemic in 2020. Although the safety of the vaccine has been investigated worldwide, real-world safety data is scarce in Japan. An online, real-time survey of adverse events following immunization (AEFIs) with mRNA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Kaho, Hara, Azusa, Inada, Isa, Sugiyama, Daisuke, Hoshino, Takahiro, Yakoh, Takahiro, Yokoyama, Hirokazu, Urushihara, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501947/
https://www.ncbi.nlm.nih.gov/pubmed/36146539
http://dx.doi.org/10.3390/vaccines10091461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501947/
https://www.ncbi.nlm.nih.gov/pubmed/36146539
http://dx.doi.org/10.3390/vaccines10091461

Ejemplares similares